DK124884B - Analogifremgangsmåde til fremstilling af 2-brom-α-ergokryptin eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 2-brom-α-ergokryptin eller syreadditionssalte deraf.

Info

Publication number
DK124884B
DK124884B DK254369AA DK254369A DK124884B DK 124884 B DK124884 B DK 124884B DK 254369A A DK254369A A DK 254369AA DK 254369 A DK254369 A DK 254369A DK 124884 B DK124884 B DK 124884B
Authority
DK
Denmark
Prior art keywords
ergocryptine
bromo
preparation
acid addition
addition salts
Prior art date
Application number
DK254369AA
Other languages
Danish (da)
English (en)
Inventor
A Hofmann
E Flueckiger
F Troxler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK124884B publication Critical patent/DK124884B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK254369AA 1968-05-31 1969-05-09 Analogifremgangsmåde til fremstilling af 2-brom-α-ergokryptin eller syreadditionssalte deraf. DK124884B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH816868A CH507249A (de) 1968-05-31 1968-05-31 Verfahren zur Herstellung von 2-Brom-a-ergokryptin

Publications (1)

Publication Number Publication Date
DK124884B true DK124884B (da) 1972-12-04

Family

ID=4336202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK254369AA DK124884B (da) 1968-05-31 1969-05-09 Analogifremgangsmåde til fremstilling af 2-brom-α-ergokryptin eller syreadditionssalte deraf.

Country Status (19)

Country Link
US (2) US3752814A (fr)
AT (1) AT301765B (fr)
BE (1) BE733799A (fr)
BR (1) BR6909341D0 (fr)
CA (1) CA953720A (fr)
CH (1) CH507249A (fr)
CS (1) CS163736B2 (fr)
CY (1) CY780A (fr)
DE (1) DE1926045C3 (fr)
DK (1) DK124884B (fr)
FI (1) FI49035C (fr)
FR (1) FR2009737A1 (fr)
GB (1) GB1257841A (fr)
IT (1) IT7827515A0 (fr)
MY (1) MY7500028A (fr)
NL (1) NL151374B (fr)
PL (1) PL80058B1 (fr)
SE (1) SE341854B (fr)
YU (1) YU33970B (fr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920664A (en) * 1972-07-21 1975-11-18 Lilly Co Eli D-2-halo-6-alkyl-8-substituted ergolines and related compounds
US4199579A (en) * 1975-03-14 1980-04-22 Siphar S. A. Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof
US4054660A (en) * 1975-04-14 1977-10-18 Eli Lilly And Company Method of inhibiting prolactin
CH619468A5 (fr) * 1976-01-12 1980-09-30 Sandoz Ag
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
YU39786B (en) * 1976-12-23 1985-04-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-alfa-ergocriptine
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
YU39849B (en) * 1978-09-26 1985-04-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-ergolene and 2-bromo-ergoline compounds
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE3216869A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Synergistische kombination mit zytostatischer wirkung
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
JPS606815A (ja) * 1983-06-24 1985-01-14 Mitsutoyo Mfg Co Ltd 微動送り装置
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
US4659715A (en) * 1986-03-07 1987-04-21 Louisiana State University And Agricultural And Mechanical College Method of inhibiting body fat stores
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5006526A (en) * 1988-10-17 1991-04-09 Louisiana State University Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
WO1990010462A1 (fr) * 1989-03-10 1990-09-20 Endorecherche Inc. Therapie combinee pour le traitement de maladies sensibles a l'×strogene
CA2030174C (fr) * 1990-01-10 1996-12-24 Anthony H. Cincotta Procede pour la reduction a long terme des reserves lipidiques, de l'insulinoresistance, de l'hyperinsulinemie et de l'hypoglycemie chez les vertebres
US5416090A (en) * 1991-01-31 1995-05-16 Eli Lilly And Company Method of treating inflammation
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5817751A (en) * 1994-06-23 1998-10-06 Affymax Technologies N.V. Method for synthesis of diketopiperazine and diketomorpholine derivatives
US5792748A (en) * 1995-06-07 1998-08-11 The General Hospital Corporation Method for inhibiting neoplastic disease in mammals
DK0910365T3 (da) * 1996-05-01 2003-10-20 Harvard College Væksthæmning og udslettelse af faste tumorer ved at anvende en prolactinmodulator og en fotosensibilisator
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
US5874589A (en) * 1997-07-18 1999-02-23 Glaxo Wellcome, Inc. Methods for synthesizing diverse collections of tetramic acids and derivatives thereof
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US6548484B1 (en) 2000-04-12 2003-04-15 International Medical Innovations, Inc. Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
AP2007003979A0 (en) * 2004-11-23 2007-06-30 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for thetreatment of lipidemia
US8283312B2 (en) * 2005-02-04 2012-10-09 The Research Foundation Of State University Of New York Compositions and methods for modulating body weight and treating obesity-related disorders
WO2006099877A1 (fr) * 2005-03-24 2006-09-28 Atef Mohammed Mostafa Darwish Suppositoires rectaux et vaginaux contenant de la bromocriptine et un poloxamere bioadhesifs
WO2007015162A1 (fr) * 2005-08-04 2007-02-08 Pfizer Limited Composes piperidinoyl-pyrrolidine et piperidinoyl-piperidine
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
MEP6808A (xx) * 2006-02-23 2010-02-10 Lundbeck & Co As H Priperidinoilpirodolini agonisti receptora menalokortina tipa 4
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
CN101583593A (zh) 2006-11-13 2009-11-18 辉瑞产品公司 二芳基、二吡啶基和芳基-吡啶基衍生物及其用途
AU2007323193A1 (en) * 2006-11-20 2008-05-29 Glenmark Pharmaceuticals S.A. Acetylene derivatives as Stearoyl CoA Desaturase inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
WO2009037542A2 (fr) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Composés spirocycliques en tant qu'inhibiteurs de stéaroyle coa désaturase
JP5328244B2 (ja) * 2008-07-07 2013-10-30 株式会社ニュージェン・ファーマ 筋萎縮性側索硬化症治療剤
ES2421920T3 (es) * 2008-08-06 2013-09-06 Pfizer Ltd Compuestos de diazepina y diazocano como agonistas de MC4
TWI537274B (zh) 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途
WO2014092006A1 (fr) 2012-12-10 2014-06-19 キッセイ薬品工業株式会社 Nouveau dérivé d'octahydropyridoquinazoline, composition pharmaceutique le contenant, et utilisations pour ledit dérivé et ladite composition
DK3445362T3 (da) 2016-04-20 2021-10-11 Veroscience Llc Sammensætning og fremgangsmåde til behandling af stofskiftesygdomme
AU2018292939B2 (en) 2017-06-28 2022-11-24 Kyoto University Agent for preventing and/or treating Alzheimer's disease
EP4233913A3 (fr) 2017-10-18 2023-10-18 VeroScience LLC Formulations de bromocriptine améliorées

Also Published As

Publication number Publication date
DE1926045C3 (de) 1978-09-21
GB1257841A (fr) 1971-12-22
CA953720A (en) 1974-08-27
FI49035C (fi) 1975-03-10
BE733799A (fr) 1969-12-01
IT7827515A0 (it) 1978-09-11
US3752814A (en) 1973-08-14
DE1926045B2 (de) 1978-01-12
SE341854B (fr) 1972-01-17
FR2009737A1 (fr) 1970-02-06
FI49035B (fr) 1974-12-02
CH507249A (de) 1971-05-15
PL80058B1 (fr) 1975-08-30
YU33970B (en) 1978-09-08
YU133669A (en) 1978-02-28
AT301765B (de) 1972-09-25
CY780A (en) 1975-03-01
MY7500028A (en) 1975-12-31
BR6909341D0 (pt) 1973-02-08
NL6907038A (fr) 1969-12-02
CS163736B2 (fr) 1975-11-07
US3752888A (en) 1973-08-14
NL151374B (nl) 1976-11-15
DE1926045A1 (de) 1969-12-04

Similar Documents

Publication Publication Date Title
DK124884B (da) Analogifremgangsmåde til fremstilling af 2-brom-α-ergokryptin eller syreadditionssalte deraf.
DK134984B (da) Analogifremgangsmåde til fremstilling af alfa-alkylaminopropiophenoner eller syreadditionssalte heraf.
DK129446B (da) Analogifremgangsmåde til fremstilling af fenoxyhydroxypropylaminer eller syreadditionssalte heraf.
DK125417B (da) Analogifremgangsmåde til fremstilling af amino-dihalogenphenylethylaminer eller syreadditionssalte deraf.
DK139717B (da) Analogifremgangsmåde til fremstilling af beta-aryl-2-aminoalkoxystyroler eller syreadditionssalte heraf.
DK135278B (da) Analogifremgangsmåde til fremstilling af fenoksyisopropanolaminderivater eller syreadditionssalte deraf.
DK136526B (da) Analogifremgangsmåde til fremstilling af substituerede naphthylalkylaminer eller syreadditionssalte deraf.
DK125798B (da) Analogifremgangsmåde til fremstilling af pyridazinderivater eller syreadditionssalte heraf.
DK129577B (da) Analogifremgangsmåde til fremstilling af phenacetylguanidiner eller syreadditionssalte deraf.
DK131721B (da) Analogifremgangsmåde til fremstilling af adamantanylaminer eller 3,5,7-trimethylhomologe eller syreadditionssalte deraf.
DK127644B (da) Analogifremgangsmåde til fremstilling af ergopeptiner eller syreadditionssalte deraf.
DK129448B (da) Analogifremgangsmåde til fremstilling af bis-(benzylidenamino)-guanidiner eller syreadditionssalte deraf.
DK120155B (da) Analogifremgangsmåde til fremstilling af aminopropiofenoner eller syreadditionssalte deraf.
DK126327B (da) Analogifremgangsmåde til fremstilling af derivater af p-aminoalkylbenzensulfonamid eller syreadditionssalte deraf.
DK126426B (da) Analogifremgangsmåde til fremstilling af hydroxylaminderivater eller syreadditionssalte deraf.
DK125472B (da) Analogifremgangsmåde til fremstilling af pyrimidopyridazinderivater eller syreadditionssalte deraf.
DK129454B (da) Analogifremgangsmåde til fremstilling af ergonorcornin eller syreadditionssalte deraf.
DK122323B (da) Fremgangsmåde til fremstilling af 1-alkyl-(eller alkenyl)-2-aminomethylpyrrolidiner eller syreadditionssalte heraf.
DK129164B (da) Analogifremgangsmåde til fremstilling af 3-alkyl-5-aryloxymethylisoxazoler eller syreadditionssalte deraf.
DK131727B (da) Analogifremgangsmåde til fremstilling af oxazinobenzoxaziner eller syreadditionssalte deraf.
DK124028B (da) Analogifremgangsmåde til fremstilling af quinolylformiminoethere eller syreadditionssalte deraf.
DK134023B (da) Analogifremgangsmåde til fremstilling af acyloxypiperazinylforbindelser eller syreadditionssalte deraf.
DK129839B (da) Analogifremgangsmåde til fremstilling af N-vinylquinoloner eller syreadditionssalte deraf.
DK128813B (da) Analogifremgangsmåde til fremstilling af basisk substituerede thiophthalaner eller syreadditionssalte deraf.
DK129989B (da) Analogifremgangsmåde til fremstilling af basiske 2-androsten-17-ethere eller syreadditionssalte deraf.